We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01209598
First Posted: September 27, 2010
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Pfizer
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center